Spago Nanomedical receives grant from Vinnova for the development of SpagoPix

Spago Nanomedical has been granted 500 000 SEK by Sweden's government agency for innovation, Vinnova, to support the clinical development and commercialization of SpagoPix.

New Case Study from NewMindTech!

Spago Nanomedical participates in EU NANO2ALL project

LightningChart® v.8.3 released

V.8.3 with new features and error fixes is now released!

AbbVie Announces Results from Phase 2 Study Evaluating Rovalpituzumab Tesirine (Rova-T) for Third-Line Treatment of Patients with DLL3-Expressing Relapsed/Refractory Small Cell Lung Cancer

Join us at ISHLT 2018 to explore new horizons for optimizing transplantation

April 11- 14, Acropolis Congress Centre Nice, France